Active Biotech AB (ACTI) — Tangible Net Worth Ratio
Active Biotech AB (ACTI) has a Tangible Net Worth Ratio of 95.6% as of September 2025. This metric is calculated by deducting intangible assets (Skr200.00K) from net assets (Skr4.50 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital to net assets of Active Biotech AB to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Active Biotech AB Tangible Net Worth Ratio (2000–2024)
This chart shows how Active Biotech AB's Tangible Net Worth Ratio has changed across 25 annual periods from 2000 to 2024. As of September 2025, the ratio stands at 95.6%, reflecting net assets of Skr4.50 Million with intangible assets of Skr200.00K SEK. See operational self-sufficiency of Active Biotech AB to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Active Biotech AB (2000–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Active Biotech AB from 2000 to 2024, covering 25 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market value of Active Biotech AB.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 99.2% | Skr32.07 Million | Skr245.00K | Skr43.20 Million | ▲ +0.0 pp |
| 2023 | 99.2% | Skr30.67 Million | Skr245.00K | Skr44.05 Million | ▼ -0.1 pp |
| 2022 | 99.3% | Skr34.51 Million | Skr245.00K | Skr51.01 Million | ▼ -0.7 pp |
| 2021 | 100.0% | Skr46.67 Million | Skr0.00 | Skr56.80 Million | ▲ +0.0 pp |
| 2020 | 100.0% | Skr22.11 Million | Skr0.00 | Skr32.16 Million | ▲ +0.0 pp |
| 2019 | 100.0% | Skr53.78 Million | Skr0.00 | Skr66.95 Million | ▲ +0.0 pp |
| 2018 | 100.0% | Skr87.92 Million | Skr0.00 | Skr302.43 Million | ▲ +0.0 pp |
| 2017 | 100.0% | Skr77.68 Million | Skr0.00 | Skr303.81 Million | ▲ +0.0 pp |
| 2016 | 100.0% | Skr182.56 Million | Skr0.00 | Skr412.88 Million | ▲ +0.0 pp |
| 2015 | 100.0% | Skr180.60 Million | Skr0.00 | Skr449.44 Million | ▲ +0.0 pp |
| 2014 | 100.0% | Skr405.31 Million | Skr0.00 | Skr722.52 Million | ▲ +0.0 pp |
| 2013 | 100.0% | Skr405.41 Million | Skr0.00 | Skr767.81 Million | ▲ +0.0 pp |
| 2012 | 100.0% | Skr339.92 Million | Skr0.00 | Skr696.74 Million | ▲ +0.0 pp |
| 2011 | 100.0% | Skr501.99 Million | Skr0.00 | Skr858.52 Million | ▲ +0.0 pp |
| 2010 | 100.0% | Skr181.76 Million | Skr0.00 | Skr503.10 Million | ▲ +0.0 pp |
| 2009 | 100.0% | Skr188.64 Million | Skr0.00 | Skr498.50 Million | ▲ +0.0 pp |
| 2008 | 100.0% | Skr163.61 Million | Skr0.00 | Skr472.95 Million | ▲ +0.0 pp |
| 2007 | 100.0% | Skr189.57 Million | Skr0.00 | Skr489.54 Million | ▲ +0.0 pp |
| 2006 | 100.0% | Skr60.36 Million | Skr0.00 | Skr462.40 Million | ▲ +0.0 pp |
| 2005 | 100.0% | Skr176.81 Million | Skr0.00 | Skr567.86 Million | ▲ +0.0 pp |
| 2004 | 100.0% | Skr162.30 Million | Skr0.00 | Skr312.89 Million | ▲ +0.0 pp |
| 2003 | 100.0% | Skr289.58 Million | Skr0.00 | Skr345.40 Million | ▲ +0.0 pp |
| 2002 | 100.0% | Skr380.27 Million | Skr0.00 | Skr467.50 Million | ▲ +0.0 pp |
| 2001 | 100.0% | Skr678.78 Million | Skr0.00 | Skr747.74 Million | ▲ +7.3 pp |
| 2000 | 92.7% | Skr646.03 Million | Skr47.14 Million | Skr868.95 Million | — |